These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16269206)

  • 1. Preparation and characterization of SARS in-house reference antiserum.
    Zhang J; Liu Y; Hu L; Gao Q; Zhang Z; Zhang X; Chen J; Gong X; Song L; Liu Y; Li J; Li S; Huang J; Ning Y; Gao H; Qin C; Dong X; Wei J; Dong G; Yin W
    Vaccine; 2005 Dec; 23(48-49):5666-9. PubMed ID: 16269206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A serological survey on neutralizing antibody titer of SARS convalescent sera.
    Zhang JS; Chen JT; Liu YX; Zhang ZS; Gao H; Liu Y; Wang X; Ning Y; Liu YF; Gao Q; Xu JG; Qin C; Dong XP; Yin WD
    J Med Virol; 2005 Oct; 77(2):147-50. PubMed ID: 16121363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective humoral responses to severe acute respiratory syndrome-associated coronavirus: implications for the design of an effective protein-based vaccine.
    Pang H; Liu Y; Han X; Xu Y; Jiang F; Wu D; Kong X; Bartlam M; Rao Z
    J Gen Virol; 2004 Oct; 85(Pt 10):3109-3113. PubMed ID: 15448374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease-specific B Cell epitopes for serum antibodies from patients with severe acute respiratory syndrome (SARS) and serologic detection of SARS antibodies by epitope-based peptide antigens.
    Liu IJ; Hsueh PR; Lin CT; Chiu CY; Kao CL; Liao MY; Wu HC
    J Infect Dis; 2004 Aug; 190(4):797-809. PubMed ID: 15272409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a novel vesicular stomatitis virus pseudotype-based assay for detection of neutralizing antibody responses to SARS-CoV.
    Fukushi S; Mizutani T; Saijo M; Kurane I; Taguchi F; Tashiro M; Morikawa S
    J Med Virol; 2006 Dec; 78(12):1509-12. PubMed ID: 17063504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses.
    Spruth M; Kistner O; Savidis-Dacho H; Hitter E; Crowe B; Gerencer M; Brühl P; Grillberger L; Reiter M; Tauer C; Mundt W; Barrett PN
    Vaccine; 2006 Jan; 24(5):652-61. PubMed ID: 16214268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of severe acute respiratory syndrome hyperimmune globulins for intravenous injection from convalescent plasma.
    Zhang Z; Xie YW; Hong J; Zhang X; Kwok SY; Huang X; Wong SW; Wong BL;
    Transfusion; 2005 Jul; 45(7):1160-4. PubMed ID: 15987362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective serological investigation of severe acute respiratory syndrome coronavirus antibodies in recruits from mainland China.
    Yu S; Qiu M; Chen Z; Ye X; Gao Y; Wei A; Wang X; Yang L; Wang J; Wen J; Song Y; Pei D; Dai E; Guo Z; Cao C; Wang J; Yang R
    Clin Diagn Lab Immunol; 2005 Apr; 12(4):552-4. PubMed ID: 15817766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation and validation of an enzyme-linked immunosorbent assay and an immunochromatographic test for serological diagnosis of severe acute respiratory syndrome.
    Guan M; Chan KH; Peiris JS; Kwan SW; Lam SY; Pang CM; Chu KW; Chan KM; Chen HY; Phuah EB; Wong CJ
    Clin Diagn Lab Immunol; 2004 Jul; 11(4):699-703. PubMed ID: 15242944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS patients-derived human recombinant antibodies to S and M proteins efficiently neutralize SARS-coronavirus infectivity.
    Liang MF; Du RL; Liu JZ; Li C; Zhang QF; Han LL; Yu JS; Duan SM; Wang XF; Wu KX; Xiong ZH; Jin Q; Li DX
    Biomed Environ Sci; 2005 Dec; 18(6):363-74. PubMed ID: 16544518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.
    Pinto D; Park YJ; Beltramello M; Walls AC; Tortorici MA; Bianchi S; Jaconi S; Culap K; Zatta F; De Marco A; Peter A; Guarino B; Spreafico R; Cameroni E; Case JB; Chen RE; Havenar-Daughton C; Snell G; Telenti A; Virgin HW; Lanzavecchia A; Diamond MS; Fink K; Veesler D; Corti D
    Nature; 2020 Jul; 583(7815):290-295. PubMed ID: 32422645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS corona virus peptides recognized by antibodies in the sera of convalescent cases.
    Guo JP; Petric M; Campbell W; McGeer PL
    Virology; 2004 Jul; 324(2):251-6. PubMed ID: 15207612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A preliminary investigation on the serological and epidemiological characteristics of severe acute respiratory syndrome in children].
    Cao L; Wang TY; Chen HZ; Qian Y; Chen BW; Fang P; Sun YX; Zhu RN; Deng J; Zhao LQ; Mi J; Zhang T
    Zhonghua Er Ke Za Zhi; 2004 Nov; 42(11):840-4. PubMed ID: 15631713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular targets for diagnostics and therapeutics of severe acute respiratory syndrome (SARS-CoV).
    Suresh MR; Bhatnagar PK; Das D
    J Pharm Pharm Sci; 2008 Apr; 11(2):1s-13s. PubMed ID: 19203466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a safe neutralization assay for SARS-CoV and characterization of S-glycoprotein.
    Han DP; Kim HG; Kim YB; Poon LL; Cho MW
    Virology; 2004 Aug; 326(1):140-9. PubMed ID: 15262502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of mammalian cells from severe acute respiratory syndrome coronavirus infection by equine neutralizing antibody.
    Wang X; Ni B; Du X; Zhao G; Gao W; Shi X; Zhang S; Zhang L; Wang D; Luo D; Xing L; Jiang H; Li W; Jiang M; Mao L; He Y; Xiao Y; Wu Y
    Antivir Ther; 2005; 10(5):681-90. PubMed ID: 16152762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Protective effect of specific antibody in serum of convalescent patient with SARS].
    Li Y; Xu J; Mo HY; Lai KF; Tan YX; Pi XY; Ren XL; Zeng GQ; Liu MF; Zhong NS
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Jul; 16(7):409-12. PubMed ID: 15238177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on the dynamics of IgG antibody in 311 patients with severe acute respiratory syndrome].
    Fan BX; Xie LX; Chen LA; Chen WJ; Wen J; Liu YN
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Mar; 26(3):194-6. PubMed ID: 15941507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-dependent enhancement of SARS coronavirus infection and its role in the pathogenesis of SARS.
    Yip MS; Leung HL; Li PH; Cheung CY; Dutry I; Li D; Daëron M; Bruzzone R; Peiris JS; Jaume M
    Hong Kong Med J; 2016 Jun; 22(3 Suppl 4):25-31. PubMed ID: 27390007
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins.
    Wang SF; Tseng SP; Yen CH; Yang JY; Tsao CH; Shen CW; Chen KH; Liu FT; Liu WT; Chen YM; Huang JC
    Biochem Biophys Res Commun; 2014 Aug; 451(2):208-14. PubMed ID: 25073113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.